1-12 of 12
Junfang Yang, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia

Junfang Yang, MD, Pengfei Jiang, Xian Zhang, MD, Xiaobin Zhu, Qi Dong, Jiaping He, Nanjing Lin, Zhenguang Wang, Songbai Cai, Xun Ye, Yunchao Su, Wenqian Li, Jingjing Li, Ziyao Yu, Jiujiang He, Li Xu, Dan Song, Wei Cao, Peihua Lu
Journal: Blood
Blood (2019) 134 (Supplement_1): 284.
https://doi.org/10.1182/blood-2019-126429
Published: 2019
Journal Articles

Analysis of Factors Predicting Treatment Response of 254 Patients Who Received CD19-Targeted CAR-T Cell Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Xian Zhang, MD, Junfang Yang, MD, Yanze Shi, Dan Song, Jingjing Li, Xin-an Lu, PhD, Fei Wu, Jianqiang Li, Ph. D., Dandan Chen, Xiangqun Li, Zhongwei Xu, Shuqiang Liu, Ziyu Li, Kui YIng, Wenya Wang, Peihua Lu
Journal: Blood
Blood (2019) 134 (Supplement_1): 224.
https://doi.org/10.1182/blood-2019-125503
Published: 2019
Journal Articles

Surface Density of CAR Molecules May Modulate the Kinetics of CAR-T Cells In Vivo

Jianqiang Li, PhD, Jin-Yuan Ho, PhD, Lin Wang, Xing Niu, Min Ba, Qinglong Wang, Junfang Yang, MD, Xian Zhang, MD, Dandan Chen, Peihua Lu
Journal: Blood
Blood (2019) 134 (Supplement_1): 54.
https://doi.org/10.1182/blood-2019-125467
Published: 2019
Journal Articles

A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia

Junfang Yang, MD, Jiaping He, Xian Zhang, MD, Zhenguang Wang, Yongliang Zhang, Songbai Cai, Zhe Sun, Xun Ye, Yan He, Lianjun Shen, MD PhD, Jiujiang He, Gailing Zhang, MD, Dan Song, Min Zhang, Xiaona Hu, Jingjing Li, Shulian Xia, Li Xu, Wei Cao, Peihua Lu
Journal: Blood
Blood (2019) 134 (Supplement_1): 825.
https://doi.org/10.1182/blood-2019-121751
Published: 2019
Journal Articles

A Long-Term Retrospective Analysis of Arsenic-Containing Triple-Agents Treatment for Acute Promyelocytic Leukemia (APL) in a Cohort from a Single Hospital

Xian Zhang, PhD, Junfang Yang, MD, Fanyong LV, Gailing Zhang, MD, Yunchao Su, MD, Peihua Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 4060.
https://doi.org/10.1182/blood-2018-99-117795
Published: 2018
Journal Articles

CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia

Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Zhijie Wei, Ruijuan Sun, Jiarui Zhou, Yue Lu, Xingyu Cao, Junfang Yang, MD, Xian Zhang, PhD, Hui Wang, PhD, Hongxing Liu, MD, Peihua Lu, Daopei Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 2660.
https://doi.org/10.1182/blood-2018-99-118852
Published: 2018
Journal Articles

A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia

Junfang Yang, MD, Jianqiang Li, Xian Zhang, PhD, Fanyong LV, Xiaoling Guo, Qinglong Wang, Lin Wang, Dandan Chen, Xiaosu Zhou, Jinhai Ren, MD, Peihua Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 277.
https://doi.org/10.1182/blood-2018-99-114415
Published: 2018
Journal Articles

Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

Xian Zhang, PhD, Xin-an Lu, Junfang Yang, MD, Fanyong LV, Min Xiong, Jianping Zhang, Xiaosu Zhou, Ting He, Peihua Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 280.
https://doi.org/10.1182/blood-2018-99-115642
Published: 2018
Journal Articles

A 11-Year Clinical Summary of DC - CIK / NK Cell Immunotherapy for 152 Patients with Acute Myeloid Leukemia

Xian Zhang, PhD, Junfang Yang, MD, Gailing Zhang, MD, Peggy (Pei-Hua) Lu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1369.
https://doi.org/10.1182/blood.V130.Suppl_1.1369.1369
Published: 2017
Journal Articles

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Biping Deng, MD, Alex Hongsheng Chang, Professor, Junfang Yang, MD, Jing Pan, MD, Xian Zhang, PhD, Yuehui Lin, MD, Yanan Wu, MD, Zhenling Deng, PhD, Peihua Lu, MD, Tong Wu, MD, Zhaoli Liu, Bachelor, Yu'e Zhang, Bachelor, Chunrong Tong, MD
Journal: Blood
Blood (2016) 128 (22): 649.
https://doi.org/10.1182/blood.V128.22.649.649
Published: 2016
Journal Articles

Mutaome Profiling and Retrospective Mutaome Profiling Using Archived Bone Marrow Smear In AML

Hongxing Liu, MD, Fang Wang, MD, Wen Teng, Yuehui Lin, MD, Junfang Yang, MD., Xian Zhang, Qing Yin, Xue Chen, Ping Zhu, MD, Chunrong Tong, MD
Journal: Blood
Blood (2013) 122 (21): 4983.
https://doi.org/10.1182/blood.V122.21.4983.4983
Published: 2013
Journal Articles

Predictable Recurrence by Regular Monitoring Minimal Residual Disease with Flowcytometry In the Patients with Both AML and ALL: A Single-Center Study of 158 Cases.

Chunrong Tong, MD, Junfang Yang, MD, Yuehui Lin, MD, Xinhong Fei, MD, Jie Zhao, MD, Xian Zhang, MD, Jiangying Gu, MD, Tong Wu, MD, Dao-Pei Lu, MD, Hui Wang, MD
Journal: Blood
Blood (2010) 116 (21): 1661.
https://doi.org/10.1182/blood.V116.21.1661.1661
Published: 2010